Menon et al reported the GRASPS score for predicting symptomatic intracranial hemorrhage for patients following intravenous thrombolytic therapy for ischemic stroke. The authors are from University of Calgary, University of California Los Angeles, Northwestern University, Michigan State University, Duke University and Massachusetts General Hospital..Data was from the Get With The Guidelines-Stroke (GWTG-Stroke) trial.